Rachel Frank | executive |
Sanj Patel | executive |
Ross Moat | executive |
John Paolini | executive |
Mark Ragosa | executive |
Anupam Rama | analyst |
Kyuwon Choi | analyst |
David Nierengarten | analyst |
Eben Tessari | executive |
Geoffrey Meacham | analyst |
Liisa Bayko | analyst |
Good day, and thank you for standing by, and welcome to Kiniksa Pharmaceuticals' First Quarter 2024 Earnings Conference Call. [Operator Instructions] Please be advised that today's conference is being recorded.
I would now like to hand the conference over to your speaker today, Rachel Frank, Head of Investor Relations. Please go ahead.
Thank you, operator.